SCHEMBL9750357

SCHEMBL9750357

COC(=O)CC(C)c1nsnc1OCC(O)CN(O)C(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.34
ADRB2 P07550 1/20 0.34
ADRB1 P08588 1/20 0.34
CYP3A4 P08684 1/20 0.34
HTR1A P08908 1/20 0.34
CYP2D6 P10635 1/20 0.34
ADRB3 P13945 1/20 0.34
NFKB1 P19838 1/20 0.34
DRD1 P21728 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
BLM P54132 1/20 0.34
GAA P10253 1/20 0.32
TSHR P16473 1/20 0.32
ABCB1 P08183 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10980202 0.89 KDM4E (0.32) CYP1A2ADRB2ADRB1CYP3A4HTR1A
SCHEMBL9749830 0.82 ADRB2 (0.52) CYP1A2ADRB2ADRB1CYP3A4HTR1A
SCHEMBL9749844 0.80 ADRB2 (0.47) CYP1A2ADRB2ADRB1CYP2D6ADRB3
SCHEMBL10992536 0.80 CYP1A2 (0.42) CYP1A2ADRB2ADRB1CYP3A4HTR1A
SCHEMBL9749863 0.79 ADRB2 (0.33) CYP1A2ADRB2ADRB1CYP3A4HTR1A
SCHEMBL10982702 0.76 ADRB2 (0.44) CYP1A2ADRB2ADRB1CYP3A4HTR1A
SCHEMBL10992310 0.75 ADRB2 (0.36) CYP1A2ADRB2ADRB1CYP3A4HTR1A
SCHEMBL9749911 0.75 ABCB1 (0.39) ADRB2ADRB1ADRB3GAATSHR
SCHEMBL10991811 0.74 ADRB1 (0.43) CYP1A2ADRB2ADRB1CYP3A4HTR1A
SCHEMBL9750424 0.73 ADRB2 (0.49) CYP1A2ADRB2ADRB1CYP3A4HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0131006-B1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-06-10 EP disclosed
US-4508725-A BETA-ADRENERGIC BLOCKING AGENTS; GLAUCOMA TREATMENT AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1985-04-02 US disclosed